Motohiro Murakami

421 total citations
30 papers, 273 citations indexed

About

Motohiro Murakami is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Hepatology. According to data from OpenAlex, Motohiro Murakami has authored 30 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 6 papers in Hepatology. Recurrent topics in Motohiro Murakami's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Radiation Therapy and Dosimetry (6 papers) and Liver Disease Diagnosis and Treatment (3 papers). Motohiro Murakami is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Radiation Therapy and Dosimetry (6 papers) and Liver Disease Diagnosis and Treatment (3 papers). Motohiro Murakami collaborates with scholars based in Japan, United States and Netherlands. Motohiro Murakami's co-authors include Hideyuki Sakurai, Carol Kruchko, Bridget J. McCarthy, Therese A. Dolecek, Soichiro Shibui, Ayako Matsuda, Yoshitaka Narita, Tomotaka Sobue, Hitoshi Ishikawa and John L. Villano and has published in prestigious journals such as PLoS ONE, Annals of Oncology and Cancers.

In The Last Decade

Motohiro Murakami

27 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Motohiro Murakami Japan 8 101 95 88 34 33 30 273
Jung Ho Im South Korea 9 99 1.0× 39 0.4× 115 1.3× 23 0.7× 23 0.7× 22 272
Yiat Horng Leong Singapore 7 66 0.7× 102 1.1× 104 1.2× 38 1.1× 16 0.5× 13 287
Sedat Türkan Türkiye 8 145 1.4× 85 0.9× 83 0.9× 48 1.4× 10 0.3× 10 295
Mihir Shanker Australia 9 61 0.6× 40 0.4× 67 0.8× 26 0.8× 15 0.5× 28 247
John H. Suh United States 7 53 0.5× 101 1.1× 235 2.7× 30 0.9× 9 0.3× 9 326
Andreas O. Schueler Germany 10 60 0.6× 46 0.5× 84 1.0× 45 1.3× 21 0.6× 12 358
Vimoj Nair Canada 11 43 0.4× 114 1.2× 145 1.6× 32 0.9× 8 0.2× 32 308
Caressa Hui United States 10 84 0.8× 78 0.8× 88 1.0× 27 0.8× 18 0.5× 47 344
Eren Celik Germany 11 52 0.5× 55 0.6× 112 1.3× 16 0.5× 16 0.5× 25 270
Theodore E. Yaeger United States 6 37 0.4× 62 0.7× 118 1.3× 31 0.9× 13 0.4× 10 248

Countries citing papers authored by Motohiro Murakami

Since Specialization
Citations

This map shows the geographic impact of Motohiro Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motohiro Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motohiro Murakami more than expected).

Fields of papers citing papers by Motohiro Murakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Motohiro Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motohiro Murakami. The network helps show where Motohiro Murakami may publish in the future.

Co-authorship network of co-authors of Motohiro Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Motohiro Murakami. A scholar is included among the top collaborators of Motohiro Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Motohiro Murakami. Motohiro Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakai, Kei, Hiroaki Kumada, Yoshitaka Matsumoto, et al.. (2025). Boron neutron capture therapy (BNCT) phase I clinical trial for newly diagnosed glioblastoma by newly developed accelerator at University of Tsukuba. Applied Radiation and Isotopes. 226. 112152–112152. 1 indexed citations
2.
Mizumoto, Masashi, Toshiyuki Okumura, Hirokazu Makishima, et al.. (2024). Proton Beam Therapy for Treating Patients with Hepatocellular Carcinoma with Major Portal Vein Tumor Invasion: A Single Center Retrospective Study. Cancers. 16(11). 2050–2050. 5 indexed citations
4.
Ishikawa, Hitoshi, Motohiro Murakami, Masatoshi Nakamura, et al.. (2023). Clinical Impact of Proton Beam Therapy for Postoperative Lymph Node Oligorecurrence of Esophageal Cancer. In Vivo. 37(3). 1253–1259. 3 indexed citations
5.
Saito, Takashi, Masahiro Nakayama, Kayoko Ohnishi, et al.. (2023). Proton beam therapy in multimodal treatment for locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus. Radiation Oncology. 18(1). 106–106. 2 indexed citations
6.
Iizumi, Takashi, Toshiyuki Okumura, Naoyuki Hasegawa, et al.. (2023). Proton beam therapy for hepatocellular carcinoma with bile duct invasion. BMC Gastroenterology. 23(1). 267–267. 5 indexed citations
7.
Nakamura, Masatoshi, Kayoko Ohnishi, Takashi Saito, et al.. (2022). Proton Beam Therapy in Elderly Patients With cT1-3N0M0 Non-small Cell Lung Cancer. Anticancer Research. 42(6). 2953–2960. 4 indexed citations
8.
Mizumoto, Masashi, Yoshiko Oshiro, Toshio Miyamoto, et al.. (2022). Olfactory Sensations During Proton and Photon Radiotherapy: A Multicenter Prospective Observational Study. Cureus. 14(3). e22964–e22964. 4 indexed citations
9.
Mizumoto, Masashi, Yoshiko Oshiro, Toshio Miyamoto, et al.. (2022). Light flash and odor during proton beam therapy for pediatric patients: a prospective observational study. Frontiers in Oncology. 12. 863260–863260. 2 indexed citations
10.
Murakami, Motohiro, et al.. (2022). A Case Report of Radiotherapy for Skull Lesions of Langerhans Cell Histiocytosis With Dural Invasion. Cancer Diagnosis & Prognosis. 2(2). 258–262. 1 indexed citations
11.
Iizumi, Takashi, Toshiyuki Okumura, Kazushi Maruo, et al.. (2021). 943P Long-term outcome of the oldest-old patients (85 years or older) underwent proton beam therapy for hepatocellular carcinoma. Annals of Oncology. 32. S824–S824.
12.
Ishikawa, Hitoshi, Motohiro Murakami, Masatoshi Nakamura, et al.. (2021). Proton Beam Therapy for Local Recurrence of Rectal Cancer. Anticancer Research. 41(7). 3589–3595. 15 indexed citations
13.
Shimizu, Shosei, Masashi Mizumoto, Toshiyuki Okumura, et al.. (2021). Proton beam therapy for a giant hepatic hemangioma: A case report and literature review. Clinical and Translational Radiation Oncology. 27. 152–156. 7 indexed citations
14.
Ishikawa, Hitoshi, Masatoshi Nakamura, Motohiro Murakami, et al.. (2021). The impact of lymphopenia during chemoradiotherapy using photons or protons on the clinical outcomes of esophageal cancer patients. Journal of Radiation Research. 13 indexed citations
15.
Mizumoto, Masashi, Yoshiko Oshiro, Motohiro Murakami, et al.. (2020). Transitions of Liver and Biliary Enzymes during Proton Beam Therapy for Hepatocellular Carcinoma. Cancers. 12(7). 1840–1840. 5 indexed citations
16.
Murakami, Motohiro, Hitoshi Ishikawa, Shosei Shimizu, et al.. (2020). Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group. Cancers. 12(6). 1690–1690. 6 indexed citations
17.
Ishikawa, Hitoshi, Hiroshi Tsuji, Shigeyuki Murayama, et al.. (2019). Particle therapy for prostate cancer: The past, present and future. International Journal of Urology. 26(10). 971–979. 33 indexed citations
19.
McCarthy, Bridget J., Soichiro Shibui, Takamasa Kayama, et al.. (2012). Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. Neuro-Oncology. 14(9). 1194–1200. 113 indexed citations
20.
Murakami, Motohiro, et al.. (1991). 403 High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) in patients with Stage III/IV ovarian cancer.. 日本産科婦人科學會雜誌. 43(8). 1075. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026